Clinical trial
Prospective Observational Study About Progress of Subjective Well-being Sensation in Schizophrenic Patients
NCT00782899 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Observational Study About Progress of Subjective Well-being Sensation in Schizophrenic Patients
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2008
- Completion date
- September 30, 2009
- Enrollment
- 320 (estimated)
- Sites
- 65
Conditions
As the registry lists them; a condition with its own page is linked.